JUN 23, 2015 12:03 PM PDT

The Cost of Bad Data

WRITTEN BY: Kerry Evans
The United States loses $28 billion on irreproducible pre-clinical research every year. Leonard Freedman, Iain Cockburn, and Timothy Simcoe tabulate this figure in their recent PLOS Biology article (http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002165). They also offer solutions to the problem of irreproducibility in the pre-clinical and life sciences, an issue addressed by the National Institutes of Health (NIH) in 2012 with their Reproducibility Initiative and commented on by microbiologists Arturo Casadevall and Ferric Fang in Infection and Immunity (http://iai.asm.org/content/80/3/897.full and http://iai.asm.org/content/80/3/891.full).
Irreproducible data costs the US an estimated $28 billion each year.
Freedman contends that roughly 50% of pre-clinical research conducted annually in the U.S. is irreproducible, costing around $28 billion, half of the total $56.4 billion spent on pre-clinical research. He defines irreproducibility as "the existence and propagation of one or more errors, flaws, inadequacies, or omissions that prevent replication of results." Freedman also identifies four primary causes of irreproducibility: 1) study design, 2) biological reagents and reference materials, 3) laboratory protocols, and 4) data analysis and reporting.

He suggests the solution lies in a standard of best practices similar to those developed for the Internet by the World Wide Web Consortium (W3C) and the Internet Engineering Task Force (IETF). Specifically, Freedman suggests applying such standards to the problem of misidentified cancer cell lines. The NIH funds roughly $3.7 billion in research annually using cell lines, and Freedman estimates roughly a quarter of this work is irreproducible due to contaminated or misidentified lines. What's more, Freedman's organization, the Global Biological Standards Institute, has already launched a campaign aimed at authenticating cell lines (http://www.gbsi.org/work/authenticate/).

Too melodramatic? Critics think so. Stefano Bertuzzi, executive director of the American Society for Cell Biology, posted a rebuttal on the society's blog (http://ascb.org/imaginary-numbers-and-the-real-irreproducibility-crisis-in-preclinical-research/), and according to Ferric Fang, "to suggest that 50% of research dollars are being wasted is ridiculous and unhelpful" (Science Insider).

(Sources: PLOS Biology, www.the-scientist.com, Infection and Immunity, www.news.sciencemag.org, www.gbsi.org, www.ascb.org)
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
APR 29, 2020
Clinical & Molecular DX
APR 29, 2020
Move and Detect : Diagnosis of Neonatal Sepsis Using Fluorescent Micromotors
According to the World Health Organization (WHO), sepsis occurs when the body’s response to an infection injures i ...
MAY 12, 2020
Immunology
MAY 12, 2020
Disabling Genes in Immune Cells Prevents Obesity
Obesity is a $1.7 trillion problem in the United States — a value almost 10% of the nation’s gross domestic ...
MAY 11, 2020
Cell & Molecular Biology
MAY 11, 2020
3D Cell Culture Model Suggests Herpes Can Cause Alzheimer's
Alzheimer's is a common form of dementia that affects as many as 5.5 million Americans and the incidence is increasing a ...
MAY 13, 2020
Health & Medicine
MAY 13, 2020
Studying Skates for the Future of Cartilage Therapy
According to the Marine Biological Laboratory (MBL) at the University of Chicago, nearly 25% of Americans have arthritis ...
MAY 15, 2020
Cardiology
MAY 15, 2020
Cardiovascular Disease Mortality is Greater in Rural Areas
A wide variation in cardiovascular disease mortality rates has been noted among counties in the United States. Residents ...
MAY 16, 2020
Cancer
MAY 16, 2020
Red Blood Cells: More than just an Oxygen Delivery Service
The human body is a complex network of systems that often interact and affect each other. Recent work shows that red blo ...
Loading Comments...